BEAM
Beam Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$26.33-4.36%
Price as of Jul 20, 2026
BEAM valuation
Beam Therapeutics Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 61.72x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.33x
- Price / sales
- 16.52x
- Price / cash flow
- -7.33x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 10.66x
- EV / EBITDA
- -54.57x
- EV / EBIT
- -4.70x
- Market cap
- $2.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.